SCHEMBL19475402

SCHEMBL19475402

Nc1ccc(-c2cc(C(=O)O)c3cccc(Cl)c3n2)nc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HAVCR2 Q8TDQ0 1/20 0.55
MOK Q9UQ07 1/20 0.47
MEN1 O00255 5/20 0.46
KMT2A Q03164 5/20 0.46
RXFP1 Q9HBX9 4/20 0.46
EIF4A1 P60842 1/20 0.45
POLB P06746 2/20 0.45
PPARG P37231 1/20 0.45
NR2E3 Q9Y5X4 1/20 0.45
NCOR2 Q9Y618 1/20 0.45
ALDH1A1 P00352 1/20 0.45
PPARA Q07869 1/20 0.44
LMNA P02545 2/20 0.44
KDM4E B2RXH2 1/20 0.44
HTT P42858 1/20 0.44
NPSR1 Q6W5P4 2/20 0.43
PDE10A Q9Y233 1/20 0.42
USP2 O75604 1/20 0.41
MAPK1 P28482 1/20 0.41
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19475456 0.84 PPARA (0.56) HAVCR2EIF4A1ALDH1A1PPARALMNA
SCHEMBL19475407 0.81 RXFP1 (0.65) HAVCR2MEN1KMT2ARXFP1EIF4A1
SCHEMBL19475304 0.81 MOK (0.73) MOKPOLBALDH1A1LMNAKDM4E
SCHEMBL19475339 0.81 NPC1 (0.63) MEN1KMT2ARXFP1POLBPPARG
SCHEMBL19475333 0.81 HAVCR2 (0.55) HAVCR2MOKEIF4A1ALDH1A1PPARA
SCHEMBL8619739 0.78 PPARA (0.69) MEN1KMT2AEIF4A1POLBPPARA
SCHEMBL19475342 0.78 PTGES (0.61) MOKMEN1KMT2ARXFP1EIF4A1
SCHEMBL15129827 0.73 HAVCR2 (0.50) HAVCR2MEN1KMT2AEIF4A1ALDH1A1
SCHEMBL16833684 0.72 HAVCR2 (0.50) HAVCR2EIF4A1PPARALMNAKDM4E
SCHEMBL436716 0.72 HAVCR2 (1.00) HAVCR2MEN1KMT2AALDH1A1PPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192859-B2 Quinoline compounds as modulators of RAGE activity and uses thereof UNIV NEW YORK (US) 2021-12-07 US disclosed
US-11192859-B2 Quinoline compounds as modulators of RAGE activity and uses thereof UNIV NEW YORK (US) 2021-12-07 US disclosed
US-20190194136-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF UNIV NEW YORK (US) 2019-06-27 US disclosed
US-20190194136-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF UNIV NEW YORK (US) 2019-06-27 US disclosed
WO-2017184547-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY (US) 2017-10-26 WO disclosed
WO-2017184547-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY (US) 2017-10-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190194136-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF AGER, HMGB1, GPR119 HAVCR2 2115/4885MOK 4420/4885MEN1 3331/4885
US-11192859-B2 Quinoline compounds as modulators of RAGE activity and uses thereof AGER, HMGB1, GPR119 HAVCR2 2115/4885MOK 4420/4885MEN1 3331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.